Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02432274
Title Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Limited
Indications
Therapies
Age Groups: child
Covered Countries USA | ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Texas Children's Hospital Houston Texas 77030 United States Details
CHU Strasbourg - Hopital Hautepierre Strasbourg Bas Rhin France Details
Centre Oscar Lambret Lille Lille Rhone France Details
Centre Leon Berard Lyon Rhone France Details
CHU Nantes - Hopital Mere-Enfant Nantes France Details
Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris Paris France Details
Institut Gustave Roussy Paris France Details
CHU de Toulouse - Hopital des Enfants Toulouse France Details
Universitaetsklinikum Muenster Muenster Germany Details
Kinderklinik des Olga hospitals Stuttgart Germany Details
Istituto Ortopedico Rizzoli Bologna Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy Details
Ospedale Pediatrico Bambino Gesu Roma Italy Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
Hospital Infantil Universitario Nino Jesus Madrid Spain Details
Hospital Universitario y Politecnico La Fe Hospital La Fe Valencia Valencia Spain Details
Birmingham Children's Hospital Birmingham United Kingdom Details
University College London Hospital London United Kingdom Details
Royal Victoria Infirmary Newcastle United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field